PAR PHARMACEUTICAL COMPANIES, INC.

Inactive Instrument

Par Pharmaceutical Companies, Inc. Stock

Stocks

US69888P1066

Pharmaceuticals

End-of-day quote NYSE Other stock markets
- ^USD	-

15-05-18

Endo : pushes further into generics with $8 billion Par Pharma buy

RE

on all subscriptions*

Enjoy this offer

* See conditions under "Our services"

Latest news : Par Pharmaceutical Companies, Inc.

15-05-18

Endo : pushes further into generics with $8 billion Par Pharma buy

RE

Press Releases: Par Pharmaceutical Companies, Inc.

13-01-18	Par Pharmaceutical Companies, Inc. : Par Pharmaceutical Begins Shipment of Generic Lamictal® XR	PU
13-01-02	Par Pharmaceutical Companies, Inc. : Par Pharmaceutical Begins Shipment of Rizatriptan Benzoate Tablets	PU
12-12-05	Par Pharmaceutical Companies, Inc. : Par Pharmaceutical Begins Shipment of Generic Atacand HCT®	PU
12-11-30	Par Pharmaceutical Companies, Inc. : Par Pharmaceutical Begins Shipment of Generic Symbyax®	PU
12-10-29	Par Pharmaceutical Companies, Inc. : Par Pharmaceutical Acquires Rights To Market And Distribute Generic Seroquel Xr® In The U.S.	PU

More press releases

News in other languages: Par Pharmaceutical Companies, Inc.

15-05-18	Endo rachète Par Parma pour créer un géant des génériques
15-05-18	Altera : Wall Street débute la semaine sans tendance
15-05-18	Wall Street débute la semaine sans tendance
15-05-18	Accenture : Les valeurs à suivre sur les marchés américains
15-05-18	Endo : rachète le génériqueur Par Pharmaceuticals

Managers and Directors: Par Pharmaceutical Companies, Inc.

Manager	Title	Age	Since
Paul Campanelli CEO	Chief Executive Officer	64	2012-08-31

Director	Title	Age	Since
Paul Campanelli BRD	Director/Board Member	64	2012-08-31

Generic Pharmaceuticals

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
	SUN PHARMACEUTICAL INDUSTRIES LTD.	-0.29%	+0.67%	+6.69%	+82.18%	45.85B
	OTSUKA HOLDINGS CO., LTD.	+2.56%	+3.70%	+47.72%	+91.64%	33.63B
	CIPLA LIMITED	-0.59%	-1.06%	-8.77%	+37.57%	11.81B
	ZYDUS LIFESCIENCES LIMITED	-0.86%	-0.82%	+10.64%	+96.43%	11.59B
	KRKA, D. D.	+1.54%	+3.12%	+40.43%	+132.60%	9.28B
	GEDEON RICHTER	-1.73%	-1.89%	+18.15%	+42.12%	7.33B
	ONO PHARMACEUTICAL CO., LTD.	+0.07%	+2.37%	+45.12%	-17.90%	6.65B
	GLENMARK PHARMACEUTICALS LIMITED	+0.00%	-0.91%	+29.15%	+235.70%	6.44B
	SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	-3.10%	-2.79%	-44.79%	-6.76%	5.16B
	Average	-0.21%	-0.29%	+16.04%	+77.06%	15.3B
	Weighted average by Cap.	+0.39%	-0.37%	+19.58%	+82.15%

See all sector performances

Company Profile

Employees

-

Sector

Pharmaceuticals

More about the company

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!

SEIZE THE OFFER!